Moreover, the study by Jung et al. (2019) showed that asprosin treatment results in glucose intolerance and insulin resistance in mice, as well as in increased ER stress and circulating levels of pro-inflammatory cytokines, including MCP-1, TNFα and IL-6 [24]. This evidence concerns the gene IL6 and Glucose intolerance.